King's Commercialisation Institute facilitates and accelerates innovation and commercialisation of life science research within King's College London and King's Health Partners. Working closely with Schools, Divisions, BRCs and Clinical Academic Groups (CAGs), the Institute has both outward and inward facing roles.
Every year the Commercialisation Institute runs a commercial triage process to identify the most promising research projects from within King’s Health Partners and provides Health Accelerator funding and internal project support so they can carry out commercial translational work with the aim of bringing the project to a point where it is ready for a commercial transaction. Through this approach, the Institute better understands the financial needs of the research portfolio enabling it to more effectively secure timely private equity investment or licensee engagement required for a technology’s development, commercialisation and delivery of benefits for patients. Funding and support from King’s Commercialisation Institute thus complements and enhances the effectiveness of work undertaken through existing funding streams with an intensified focus on achieving a strategic development plan that delivers for investors, industry and the benefit of patients.
Click to enlarge image.
Health Accelerator funding and support provided by the Commercialisation Institute is directed mainly towards a project’s Proof of Principle/Proof of Concept phase, where the addition of commercial insight can add significant advantage. The Institute aims is to build more commercial acumen into the envisioned application of research by incorporating more innovation 'pull' (achieving the desired utility benefits) within the existing research 'push' environment.
Organisationally, we have a Director and three Commercial Portfolio Managers, (meet the team) who have extensive industrial and commercial experience who have an extensive network of specialist, external consultants with relevant development, commercial and regulatory expertise that are engaged to address the development and commercialisation issues of a particular project. This allows us to tap into expertise that would not normally be available internally whilst remaining flexible to the demands of a broad and diverse range of innovative research projects. A King’s Commercialisation Institute Portfolio Manager works closely with the King’s researcher’s team and a manager from IP and Licensing to integrate technical, commercial and investment plans whilst managing external consultants engaged on the project. By this means a comprehensive development package can be put in place to make an attractive proposition for a licensee or investor.